Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.5804
+0.0029 (0.50%)
Nov 21, 2025, 10:52 AM EST - Market open
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $93.85 million as of November 21, 2025. Its market cap has decreased by -21.14% in one year.
Market Cap
93.85M
Enterprise Value
5.82M
1-Year Change
-21.14%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $93.85M, a decrease of -68.89%. That is a compound annual growth rate of -20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2025 | 93.38M | 6.85% |
| Dec 31, 2024 | 87.39M | 7.13% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 922.29B |
| Johnson & Johnson | 481.86B |
| AbbVie | 413.34B |
| UnitedHealth Group | 284.05B |
| AstraZeneca | 276.37B |
| Novartis AG | 244.75B |
| Merck & Co. | 239.34B |
| Abbott Laboratories | 226.05B |